Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Osteopore Ltd. ( (AU:OSX) ) has issued an announcement.
Osteopore Limited reported a revenue of AUD 812K for the third quarter of 2025, marking a 7% year-over-year growth. The company also achieved a significant milestone by securing market approval in Switzerland under the EU MDR clearance for its custom orthopedic and cranial implants, potentially enhancing its market presence in Europe.
More about Osteopore Ltd.
Osteopore Limited is a manufacturer in the medical industry, specializing in regenerative implants that facilitate natural tissue regeneration. The company focuses on producing custom orthopedic and cranial implants.
Average Trading Volume: 2,249,635
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.61M
See more data about OSX stock on TipRanks’ Stock Analysis page.